Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Airbnb shares climbed 0.6% in pre-market trading after Raymond James elevated the stock from Market Perform to Outperform and assigned a $200 price target, citing an "AI Founder Mode" thesis. The upgrade, paired with CEO Brian Chesky's scheduled presentation at the Goldman Sachs Communacopia + Technology Conference, and solid Q2 2026 results are ci…
Clearmind Medicine Inc. announced Yale University's IRB approval to initiate patient recruitment for Parts B and C of its Phase I/II clinical trial evaluating CMND-100, a non-hallucinogenic psychedelic-derived drug candidate targeting Alcohol Use Disorder. This milestone follows positive safety results from Part A, allowing accelerated enrollment a…
Morgan Stanley downgraded Peloton to Underweight from Equal Weight, with analyst Nathan Feather cutting his price target to $4.50 and reducing fiscal 2027 and 2028 estimates. Feather highlighted a marked contraction at the top of the funnel, steep declines in gross additions and falling connected fitness subscriber growth in fiscal 2026. He pointed…
Peloton stock fell sharply in pre-market trading after Morgan Stanley downgraded the company and cut its price target, while UBS trimmed earnings estimates and lowered its target. Analysts cited sustained weakness in subscriber growth and collapsing customer additions. Concurrent insider selling and a lack of offsetting market support contributed t…
IonQ shares climbed after the company updated its full-year 2026 revenue guidance to $450 million-$460 million following the completion of its acquisition of SkyWater Technology. The outlook incorporates SkyWater’s contributions from the July 31, 2026 closing through year-end and removes estimated intercompany revenue tied to prior commercial arran…
Qualcomm aims to build a meaningful data-center business and management has stated a goal of $15 billion in data center revenue within three years. With a market cap near $177B, strong free cash flow and attractive multiples relative to what a scaled data-center franchise would justify, this trade buys the thesis now and targets a re-rate as hypers…
Bloom Energy (BE) is showing the makings of an AI-memory-style frenzy: strong backlog, accelerating revenue guidance, healthy free cash flow, and technical momentum. Valuation is rich, but a disciplined swing trade can capture upside to prior highs while limiting downside. Entry $270.00, stop $235.00, target $350.00.
Nvidia reported another powerful quarter and sits on enormous cash flow, yet recent headlines - notably the proposed $12.93B Hugging Face buyout and outsized insider selling - create a risk-off dynamic that could pressure the stock over the next 45 trading days. This trade idea lays out a mid-term (45 trading days) short with a specific entry, stop…
Pyxis Oncology has appointed Thomas Civik as its Chief Executive Officer and Chairman of the Board, marking a leadership transition as the company advances key clinical milestones for its lead candidate MICVO, a novel antibody-drug conjugate for difficult-to-treat cancers. Civik brings significant industry experience, previously leading successful …
Artiva Biotherapeutics announced plans to initiate a Phase 3 registrational trial in refractory rheumatoid arthritis (RA) during the second half of 2026, alongside updated clinical data disclosures from their ongoing Phase 2a basket trial in RA, Sjögren disease, and systemic sclerosis. The company expects to present data from at least 20 RA patient…
CervoMed Inc., a clinical-stage biotech developing treatments for age-related brain disorders, announced management's participation in major September investor conferences. The company highlighted its lead drug candidate neflamapimod's progress, including a completed Phase 2b trial in dementia with Lewy bodies (DLB), discussions with the FDA on reg…
Nasus Pharma Ltd., a clinical-stage biopharmaceutical company specializing in intranasal drug delivery, announced it will participate in the upcoming H.C. Wainwright 28th Annual Global Investment Conference in New York. Management will present the company’s progress on its lead intranasal epinephrine product candidate NS002 and other pipeline devel…
BioVie Inc. announced progress in its Phase 3 clinical development program for bezisterim, a drug candidate for Parkinson's disease. The company is working with the FDA to finalize a trial design that includes motor symptom improvement as a primary endpoint and non-motor symptom improvement as a co-primary or secondary endpoint based on positive Ph…
BrainsWay Ltd. reported positive results from a peer-reviewed pilot study on their Deep Transcranial Magnetic Stimulation (Deep TMS) technology treating patients with Major Depressive Disorder and early-stage Alzheimer’s disease. The study showed an 83.3% response rate and 50% remission rate in depressive symptoms, alongside notable neurophysiologi…
BriaCell Therapeutics announced that the Memorial Sloan Kettering Cancer Center has joined its ongoing Phase 3 clinical trial of Bria-IMT combined with an immune checkpoint inhibitor for metastatic breast cancer. This expands patient access across over 80 clinical sites in 15 states and follows recent positive Phase 2 survival data and FDA Fast Tra…
OptimizeRx Corp., a healthcare technology company specializing in AI-driven engagement platforms for life sciences brands, announced its participation in the upcoming Lake Street Capital Best Ideas Growth Conference. The event provides an opportunity for management to connect with investors and showcase their innovative healthcare marketing solutio…
Bread Financial Holdings, a tech-forward financial services company providing payment, lending, and saving solutions to millions of U.S. consumers, announced its participation in the upcoming Barclays 24th Annual Global Financial Services Conference. The company's EVP and CFO will engage in a fireside chat highlighting strategic and financial topic…
Cognition Therapeutics announced that its CEO, Lisa Ricciardi, will present at the H.C. Wainwright Global Investment Conference to discuss the development progress of zervimesine (CT1812), their investigational drug for Alzheimer's disease and dementia with Lewy bodies. The company is advancing zervimesine into late-stage clinical trials based on p…
Medicus Pharma Ltd. announces a strategic transformation to become a precision oncology-led biotechnology company, prioritizing clinical development of CD228V, a second-generation antibody-drug conjugate targeting CD228 in solid tumors, with initial trials focused on melanoma. The company also plans to focus SkinJect development on Gorlin syndrome …
GE Aerospace has announced the acquisition of Consolidated Precision Products (CPP), a leading manufacturer of precision castings primarily serving commercial aerospace and defense markets. The $11.75 billion transaction is expected to be accretive to adjusted EPS and free cash flow in the first year, enhancing GE Aerospace's manufacturing capacity…
Quantum Cyber N.V. announced the acquisition and installation of a Lambda Hyperplane 8-A100 AI compute cluster powered by eight NVIDIA A100 GPUs at its Connecticut manufacturing facility. This infrastructure supports the development and deployment of the company's AI-native Swarm Operating System and battlefield command platform Quantum Station, en…
United Community Banks has finalized key strategic initiatives including the sale of Navitas Credit Corp., a significant repositioning of its investment securities portfolio to reduce interest rate risk and improve earnings, and an increased share repurchase authorization of $100 million through 2027. The company is focusing on organic loan growth,…
Citi upgraded Kion Group to 'buy' from 'neutral' and lifted its price target to €62 from €46, citing improving German macro data and signs of recovery in Kion's Industrial Trucks & Services division that together point to accelerating demand for industrial trucks into 2027. The move sent Kion shares higher by more than 6% on Tuesday.
The U.S. Treasury Department and Internal Revenue Service have proposed regulations that would revoke tax-exempt status from schools that offer programs or support targeted to particular racial groups. The proposal, citing recent U.S. Supreme Court limits on race-conscious admissions, would extend to admissions, scholarships, loans, athletics and a…
Edible Garden AG Incorporated announced its participation in ECRM's Vitamin, Weight Management & Sports Nutrition Session in September 2026, where it will highlight its Kick. Sports Nutrition line and expanding private-label ready-to-drink (RTD) products. The company aims to leverage these opportunities to expand distribution and scale its nutritio…
